Plk1 Polyclonal Antibody

Serine/threonine-protein kinase PLK1 kinase encoded by PLK1 belongs to the CDC5/Polo subfamily. It is highly expressed during mitosis and elevated levels are found in many different types of cancer. Depletion of this protein in cancer cells dramatically inhibited cell proliferation and induced apoptosis; hence, it is a target for cancer therapy.

The Plk1 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of Polo-like kinase 1 (Plk1) protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and sensitivity towards Plk1.

Plk1 is a crucial regulator of cell division and plays a pivotal role in multiple cellular processes, including mitotic entry, spindle formation, chromosome segregation, and cytokinesis. Dysregulation of Plk1 has been implicated in various diseases, including cancer, making it an attractive target for therapeutic interventions.

The Plk1 Polyclonal Antibody exhibits exceptional performance in immunohistochemistry (IHC), immunofluorescence (IF), and western blotting (WB) applications. It recognizes endogenous levels of Plk1 protein, enabling precise localization and quantification studies. With its robust and reproducible results, this antibody is an indispensable tool for researchers investigating Plk1-related cellular mechanisms and disease pathogenesis.

Furthermore, the Plk1 Polyclonal Antibody demonstrates minimal cross-reactivity with other related proteins, ensuring accurate and specific detection of Plk1. Its high specificity and sensitivity make it suitable for use in a wide range of sample types, including human, mouse, and rat tissues.

In summary, the Plk1 Polyclonal Antibody is a reliable and versatile tool for the detection and analysis of Plk1 protein expression. Its high specificity, sensitivity, and compatibility with various applications make it an essential asset for researchers in the fields of cell biology, cancer research, and drug discovery.